• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素/SUMO 修饰调节 VHL 蛋白的稳定性和核质定位。

Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization.

机构信息

Department of Microbiology and Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.

出版信息

PLoS One. 2010 Sep 9;5(9):e12636. doi: 10.1371/journal.pone.0012636.

DOI:10.1371/journal.pone.0012636
PMID:20844582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2936558/
Abstract

Functional inactivation of the von Hippel-Lindau (VHL) tumor suppressor protein is linked to the development of several forms of cancer as well as oncogenic progression like sporadic renal clear-cell carcinomas (RCC). Despite the critical role played by VHL in destruction of hypoxia-inducible factor α (HIFα) via ubiquitin-mediated proteolysis, very little is known about the post-translational modification which regulates VHL activity. Our previous study showed that the SUMO E3 ligase PIASy interacts with VHL and induces VHL SUMOylation on lysine residue 171 (Cai et al, PLoS ONE, 2010, 5(3):e9720). Here we further report that VHL also undergoes ubiquitylation on both lysine residues 171 and 196, which is blocked by PIASy. Moreover, using a VHL-SUMO1 or ubiquitin fusion protein, we found that ubiquitylated VHL is localized predominantly in the cytoplasm, while SUMOylated VHL results in increased VHL protein stability and nuclear redistribution. Interestingly, substitution of lysine 171 and 196 to arginine of VHL abrogates its inhibitory function on the transcriptional activity of HIFα, and tube formation in vitro. This demonstrates that post-translational modifications like ubiquitylation and SUMOylation contributes to VHL protein stability and nucleocytoplasmic shuttling, and that the overall function of VHL in tumor suppression may require a precise and dynamically regulated process which involves protein modification.

摘要

功能失活的 von Hippel-Lindau(VHL)肿瘤抑制蛋白与几种癌症的发展以及散发性肾透明细胞癌(RCC)等致癌进展有关。尽管 VHL 在通过泛素介导的蛋白水解破坏缺氧诱导因子α(HIFα)方面发挥着关键作用,但对于调节 VHL 活性的翻译后修饰知之甚少。我们之前的研究表明,SUMO E3 连接酶 PIASy 与 VHL 相互作用,并诱导 VHL 在赖氨酸残基 171 上的 SUMO 化(Cai 等人, PLoS ONE,2010 年,5(3):e9720)。在这里,我们进一步报告 VHL 还在赖氨酸残基 171 和 196 上发生泛素化,PIASy 会阻止这种泛素化。此外,使用 VHL-SUMO1 或泛素融合蛋白,我们发现泛素化的 VHL 主要定位于细胞质中,而 SUMO 化的 VHL 导致 VHL 蛋白稳定性增加和核重新分布。有趣的是,VHL 的赖氨酸 171 和 196 突变为精氨酸会使其抑制 HIFα 转录活性和体外管形成的功能丧失。这表明翻译后修饰(如泛素化和 SUMO 化)有助于 VHL 蛋白稳定性和核质穿梭,而 VHL 在肿瘤抑制中的整体功能可能需要一个精确和动态调节的过程,其中涉及蛋白质修饰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/aea3cb785a0a/pone.0012636.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/44ab44cb92c1/pone.0012636.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/2e154910e76e/pone.0012636.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/368d77efe4c6/pone.0012636.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/65cfac56c484/pone.0012636.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/aea3cb785a0a/pone.0012636.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/44ab44cb92c1/pone.0012636.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/2e154910e76e/pone.0012636.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/368d77efe4c6/pone.0012636.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/65cfac56c484/pone.0012636.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e8/2936558/aea3cb785a0a/pone.0012636.g005.jpg

相似文献

1
Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization.泛素/SUMO 修饰调节 VHL 蛋白的稳定性和核质定位。
PLoS One. 2010 Sep 9;5(9):e12636. doi: 10.1371/journal.pone.0012636.
2
Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.缺氧通过 PIASy 介导的 SUMO 修饰使 VHL 肿瘤抑制因子失活。
PLoS One. 2010 Mar 16;5(3):e9720. doi: 10.1371/journal.pone.0009720.
3
Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.缺氧诱导因子的氧依赖性泛素化和降解需要视网膜母细胞瘤肿瘤抑制蛋白的核质转运。
Mol Cell Biol. 2002 Aug;22(15):5319-36. doi: 10.1128/MCB.22.15.5319-5336.2002.
4
Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.冯·希佩尔-林道肿瘤抑制蛋白外显子2编码的β结构域的作用
J Biol Chem. 2001 Jan 12;276(2):1407-16. doi: 10.1074/jbc.M008295200.
5
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.转录依赖性核质运输是冯·希佩尔-林道肿瘤抑制蛋白发挥功能所必需的。
Mol Cell Biol. 1999 Feb;19(2):1486-97. doi: 10.1128/MCB.19.2.1486.
6
c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.c-Myc以一种依赖于SUMO化的方式靶向蛋白酶体进行降解,这一过程受PIAS1、SENP7和RNF4调控。
Cell Cycle. 2015;14(12):1859-72. doi: 10.1080/15384101.2015.1040965.
7
Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein.细胞核与细胞质定位在冯·希佩尔-林道蛋白抑癌活性中的作用
Oncogene. 2003 Jun 26;22(26):3992-7. doi: 10.1038/sj.onc.1206683.
8
RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha.RNF4 和 VHL 调节 SUMO 缀合的缺氧诱导因子-2α的蛋白酶体降解。
Nucleic Acids Res. 2010 Apr;38(6):1922-31. doi: 10.1093/nar/gkp1157. Epub 2009 Dec 21.
9
Molecular cloning and characterization of the von Hippel-Lindau-like protein.类希佩尔-林道蛋白的分子克隆与特性分析
Mol Cancer Res. 2004 Jan;2(1):43-52.
10
TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.TCTP 通过与肿瘤抑制因子 VHL 相互作用和降解来增加缺氧诱导因子 1α 的稳定性。
Biol Cell. 2013 May;105(5):208-218. doi: 10.1111/boc.201200080. Epub 2013 Mar 15.

引用本文的文献

1
Retinal hemangioblastoma in a patient with Von Hippel-Lindau disease: A case report and literature review.1例Von Hippel-Lindau病患者的视网膜血管瘤:病例报告及文献复习
Front Oncol. 2022 Nov 2;12:963469. doi: 10.3389/fonc.2022.963469. eCollection 2022.
2
Retraction: Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization.撤回声明:泛素/类泛素修饰调节VHL蛋白稳定性及核质定位。
PLoS One. 2022 Mar 4;17(3):e0265155. doi: 10.1371/journal.pone.0265155. eCollection 2022.
3
Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines.

本文引用的文献

1
Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.缺氧通过 PIASy 介导的 SUMO 修饰使 VHL 肿瘤抑制因子失活。
PLoS One. 2010 Mar 16;5(3):e9720. doi: 10.1371/journal.pone.0009720.
2
Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.Jade-1通过泛素化β-连环蛋白抑制Wnt信号,并通过pVHL介导Wnt通路抑制。
Nat Cell Biol. 2008 Oct;10(10):1208-16. doi: 10.1038/ncb1781. Epub 2008 Sep 21.
3
NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL.
多组学分析评估 VHL 恢复后信号变化,并鉴定透明细胞肾细胞癌细胞系中潜在的 VHL 底物。
Cells. 2022 Jan 29;11(3):472. doi: 10.3390/cells11030472.
4
SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.PAF1/PD2的小泛素样修饰物(SUMO)修饰可实现与早幼粒细胞白血病(PML)的相互作用并促进胰腺导管腺癌的辐射抗性。
Mol Cell Biol. 2021 Nov 22;41(12):e0013521. doi: 10.1128/MCB.00135-21. Epub 2021 Sep 27.
5
The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.von Hippel-Lindau Cullin-RING E3 泛素连接酶调节 APOBEC3 胞嘧啶脱氨酶。
Transl Res. 2021 Nov;237:1-15. doi: 10.1016/j.trsl.2021.05.002. Epub 2021 May 15.
6
The Function of SUMOylation and Its Role in the Development of Cancer Cells under Stress Conditions: A Systematic Review.SUMO化修饰的功能及其在应激条件下癌细胞发展中的作用:一项系统综述
Stem Cells Int. 2020 Nov 13;2020:8835714. doi: 10.1155/2020/8835714. eCollection 2020.
7
Ancient Evolutionary Origin of Intrinsically Disordered Cancer Risk Regions.内在无序的癌症风险区域的古老进化起源。
Biomolecules. 2020 Jul 28;10(8):1115. doi: 10.3390/biom10081115.
8
PHRF1 promotes migration and invasion by modulating ZEB1 expression.PHRF1 通过调节 ZEB1 表达促进迁移和侵袭。
PLoS One. 2020 Jul 30;15(7):e0236876. doi: 10.1371/journal.pone.0236876. eCollection 2020.
9
The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF.长形式的 pVHL 被丝氨酸蛋白酶抑制剂 AEBSF 人为修饰。
Protein Sci. 2020 Aug;29(8):1843-1850. doi: 10.1002/pro.3898. Epub 2020 Jun 25.
10
Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.从对疾病突变和相互作用因子的大规模分析推断出 von Hippel-Lindau 肿瘤抑制因子的基因型-表型关系。
PLoS Comput Biol. 2019 Apr 3;15(4):e1006478. doi: 10.1371/journal.pcbi.1006478. eCollection 2019 Apr.
NEDD8作为一种“分子开关”,决定了VHL的功能选择性。
EMBO Rep. 2008 May;9(5):486-91. doi: 10.1038/embor.2008.19. Epub 2008 Mar 7.
4
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.VHL缺失激活了由Rb和p400介导的不依赖HIF的衰老程序。
Nat Cell Biol. 2008 Mar;10(3):361-9. doi: 10.1038/ncb1699. Epub 2008 Feb 24.
5
The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress.冯·希佩尔-林道肿瘤抑制蛋白和Egl-9型脯氨酸羟化酶在氧化应激反应中调节RNA聚合酶II的大亚基。
Mol Cell Biol. 2008 Apr;28(8):2701-17. doi: 10.1128/MCB.01231-07. Epub 2008 Feb 19.
6
Von Hippel-Lindau disease.冯·希佩尔-林道病
Annu Rev Pathol. 2007;2:145-73. doi: 10.1146/annurev.pathol.2.010506.092049.
7
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.pVHL作为衔接蛋白,促进CK2对NF-κB激动剂Card9的抑制性磷酸化。
Mol Cell. 2007 Oct 12;28(1):15-27. doi: 10.1016/j.molcel.2007.09.010.
8
A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.卡波西肉瘤相关疱疹病毒编码的LANA氨基末端的一个潜在α-螺旋基序对于常氧下HIF-1α的核内聚集至关重要。
J Virol. 2007 Oct;81(19):10413-23. doi: 10.1128/JVI.00611-07. Epub 2007 Jul 18.
9
Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation.Oct4的类泛素化修饰增强了其稳定性、DNA结合能力和反式激活能力。
J Biol Chem. 2007 Jul 20;282(29):21551-60. doi: 10.1074/jbc.M611041200. Epub 2007 May 24.
10
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.KSHV潜伏抗原LANA招募EC5S泛素复合物以降解VHL和p53肿瘤抑制因子。
PLoS Pathog. 2006 Oct;2(10):e116. doi: 10.1371/journal.ppat.0020116.